Poland · Delayed Price · Currency is PLN BioMaxima Statistics
Total Valuation
BioMaxima has a market cap or net worth of PLN 40.59 million. The enterprise value is 55.44 million.
| Market Cap | 40.59M |
| Enterprise Value | 55.44M |
Important Dates
The next confirmed earnings date is Wednesday, September 30, 2026.
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioMaxima has 4.19 million shares outstanding.
| Current Share Class | 4.19M |
| Shares Outstanding | 4.19M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -3.45% |
| Owned by Insiders (%) | 22.38% |
| Owned by Institutions (%) | n/a |
| Float | 2.69M |
Valuation Ratios
The trailing PE ratio is 386.57.
| PE Ratio | 386.57 |
| Forward PE | n/a |
| PS Ratio | 0.67 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 12.03 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 528.04 |
| EV / Sales | 0.91 |
| EV / EBITDA | 11.27 |
| EV / EBIT | 44.89 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74
| Current Ratio | 1.74 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 0.22% and return on invested capital (ROIC) is 1.26%.
| Return on Equity (ROE) | 0.22% |
| Return on Assets (ROA) | 1.00% |
| Return on Invested Capital (ROIC) | 1.26% |
| Return on Capital Employed (ROCE) | 1.98% |
| Weighted Average Cost of Capital (WACC) | 5.82% |
| Revenue Per Employee | 451,141 |
| Profits Per Employee | 778 |
| Employee Count | 135 |
| Asset Turnover | 0.79 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioMaxima has paid 83,000 in taxes.
| Income Tax | 83,000 |
| Effective Tax Rate | 44.15% |
Stock Price Statistics
The stock price has decreased by -32.78% in the last 52 weeks. The beta is 0.29, so BioMaxima's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -32.78% |
| 50-Day Moving Average | 11.09 |
| 200-Day Moving Average | 12.23 |
| Relative Strength Index (RSI) | 29.33 |
| Average Volume (20 Days) | 5,704 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMaxima had revenue of PLN 60.90 million and earned 105,000 in profits. Earnings per share was 0.03.
| Revenue | 60.90M |
| Gross Profit | 60.90M |
| Operating Income | 1.24M |
| Pretax Income | 188,000 |
| Net Income | 105,000 |
| EBITDA | 4.92M |
| EBIT | 1.24M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 48.08M |
| Book Value Per Share | 11.47 |
| Working Capital | 11.06M |
Cash Flow
| Operating Cash Flow | 3.37M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 3.68M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 2.03% and 0.17%.
| Gross Margin | 100.00% |
| Operating Margin | 2.03% |
| Pretax Margin | 0.31% |
| Profit Margin | 0.17% |
| EBITDA Margin | 8.07% |
| EBIT Margin | 2.03% |
| FCF Margin | n/a |
Dividends & Yields
BioMaxima does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.26% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |